Abeona Therapeutics (ABEO) Dividends payables (2010 - 2014)
Abeona Therapeutics (ABEO) posted quarterly Dividends payables of $9.3 million for Q3 2014, up 58.04% year-over-year from $5.9 million in Q3 2013, and up 10.8% quarter-over-quarter from $8.4 million in Q2 2014.
Abeona Therapeutics (ABEO) Dividends payables (2010 - 2014) Analysis & Trends
Abeona Therapeutics' Dividends payables history runs 5 years deep, the most recent figure standing at $9.3 million for Q3 2014.
- In Q3 2014, Dividends payables rose 58.04% year-over-year to $9.3 million; the TTM figure through Sep 2014 stood at $9.3 million (up 58.04% YoY), while the FY2013 annual figure was $6.7 million, up 91.14% from the prior year.
- Dividends payables for Q3 2014 stood at $9.3 million, up from $8.4 million in the prior quarter.
- The five-year high for Dividends payables was $9.3 million in Q3 2014, with the low at $2.8 million in Q3 2012.
- The 5-year median for Dividends payables is $6.0 million (2011), against an average of $6.0 million.
- The sharpest annual moves came in 2012 and 2013: Dividends payables sank 53.65% in 2012, then surged 112.3% in 2013.
- Abeona Therapeutics' Dividends payables stood at $4.4 million in 2010, then soared by 46.0% to $6.5 million in 2011, then plunged by 46.26% to $3.5 million in 2012, then soared by 91.14% to $6.7 million in 2013, then soared by 39.23% to $9.3 million in 2014.
- Business Quant data shows ABEO's Dividends payables at $9.3 million in Q3 2014, $8.4 million in Q2 2014, and $7.5 million in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 9.28 Mn |
| Jun 30, 2014 | 8.37 Mn |
| Mar 31, 2014 | 7.51 Mn |
| Dec 31, 2013 | 6.66 Mn |
| Sep 30, 2013 | 5.87 Mn |
| Jun 30, 2013 | 5.03 Mn |
| Mar 31, 2013 | 4.26 Mn |
| Dec 31, 2012 | 3.49 Mn |
| Sep 30, 2012 | 2.77 Mn |
| Jun 30, 2012 | 7.52 Mn |
| Mar 31, 2012 | 7.00 Mn |
| Dec 31, 2011 | 6.49 Mn |
| Sep 30, 2011 | 5.97 Mn |
| Jun 30, 2011 | 5.45 Mn |
| Dec 31, 2010 | 4.44 Mn |